CVS Health Corp. (CVS) Stock Overview
Explore CVS Health Corp.’s financial performance, market position, analyst ratings, and future outlook.
CVS Health Corp. (CVS)
Key Financials
Key Financials
Market Cap
111.1B
P/E Ratio
22.60
EPS (TTM)
$7.84
ROE
0.06%
CVS Stock Analysis & Investment Overview (NYSE)
Our AI-powered analysis of CVS Health Corp. (NYSE: CVS) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, CVS Health Corp.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of CVS on the NYSE shows an RSI of 35.40, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $102.59 for the NYSE listing.
Key metrics behind CVS Health Corp.'s NYSE-traded stock include a P/E ratio of 22.60 and a market capitalization of 111.1B. Combined with our AI analysis, these give both institutional and retail investors a clear view of CVS on the NYSE.